Focus on anticancer therapy-induced cardiotoxicity from the perspective of oncologists

Chin Med J (Engl). 2022 Sep 5;135(17):2122-2124. doi: 10.1097/CM9.0000000000002133.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Cardiotoxicity / etiology
  • Humans
  • Neoplasms* / drug therapy
  • Oncologists*

Substances

  • Antineoplastic Agents